These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22258926)

  • 21. Tigecycline in-vitro susceptibility and antibiotics' fitness for gram-negative pathogens.
    Arya SC; Agarwal N
    Saudi Med J; 2008 Nov; 29(11):1558-60. PubMed ID: 18998000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives.
    Rizek C; Ferraz JR; van der Heijden IM; Giudice M; Mostachio AK; Paez J; Carrilho C; Levin AS; Costa SF
    J Infect Chemother; 2015 Feb; 21(2):114-7. PubMed ID: 25456893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tigecycline.
    Pankey GA
    J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
    Roveta S; Marchese A; Debbia EA
    Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
    Wroblewska MM; Rudnicka J; Marchel H; Luczak M
    Int J Antimicrob Agents; 2006 Apr; 27(4):285-9. PubMed ID: 16545949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of tigecycline against bacterial isolates from intensive care units in a teaching hospital in Central Saudi Arabia.
    Somily AM; Al-Khattaf AS; Kambal AM
    Saudi Med J; 2010 Jan; 31(1):18-24. PubMed ID: 20062893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic resistance. Nosocomial gram-negative infection.
    Gransden WR
    J Med Microbiol; 1997 Jun; 46(6):436-9. PubMed ID: 9379467
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007.
    Garrison MW; Mutters R; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):288-99. PubMed ID: 19733459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
    Shi SH; Kong HS; Xu J; Zhang WJ; Jia CK; Wang WL; Shen Y; Zhang M; Zheng SS
    Transpl Infect Dis; 2009 Oct; 11(5):405-12. PubMed ID: 19638006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug-resistant Gram-negative bacteria: how to treat and for how long.
    Giamarellou H
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S50-4. PubMed ID: 21129924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogens causing blood stream infections and their drug susceptibility profile in immunocompromised patients.
    Fayyaz M; Mirza IA; Ikram A; Hussain A; Ghafoor T; Shujat U
    J Coll Physicians Surg Pak; 2013 Dec; 23(12):848-51. PubMed ID: 24304986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
    Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C;
    Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteraemia in a tertiary care urban hospital in south India.
    Chaudhury A; Rao TV
    Indian J Pathol Microbiol; 1999 Jul; 42(3):317-20. PubMed ID: 10862291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW; Neumiller JJ; Setter SM
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of tigecycline activity in clinical isolates among Indian medical centers.
    Manoharan A; Chatterjee S; Madhan S; Mathai D
    Indian J Pathol Microbiol; 2010; 53(4):734-7. PubMed ID: 21045403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008.
    Wang YF; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):73-9. PubMed ID: 20727474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of 'new' and 'conventional' antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit.
    Ratnam I; Franklin C; Spelman DW
    Pathology; 2007 Dec; 39(6):586-8. PubMed ID: 18027263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints.
    Papaparaskevas J; Tzouvelekis LS; Tsakris A; Pittaras TE; Legakis NJ;
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):187-94. PubMed ID: 19836184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.